Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHP Merger Story: "Third Time's A Charm" Or "Three Strikes, You're Out"?

Executive Summary

American Home Products' attempt to secure a succession plan via merger has been derailed by Pfizer's competing bid for Warner-Lambert.

You may also be interested in...



Celexa May Be Hidden Trophy In Warner-Lambert Bidding War

Forest's antidepressant Celexa could either become the centerpiece of a newly created neuropharmaceutical marketing giant or an outlicensing candidate, depending on whether American Home Products or Pfizer prevails in its bid to acquire Warner-Lambert.

Pfizer Does Not Stand Still: AmericanWarner Break-Up Provision Is Hurdle

American Home Products and Warner-Lambert shared the need to complete a friendly merger to fend off two separate takeover threats.

Celexa May Be Hidden Trophy In Warner-Lambert Bidding War

Forest's antidepressant Celexa could either become the centerpiece of a newly created neuropharmaceutical marketing giant or an outlicensing candidate, depending on whether American Home Products or Pfizer prevails in its bid to acquire Warner-Lambert.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035113

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel